161 related articles for article (PubMed ID: 31966850)
21. Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.
Wu L; Zhu X; Song Z; Chen D; Guo M; Liang J; Ding D; Wang W; Yan D
Onco Targets Ther; 2019; 12():9407-9419. PubMed ID: 31819475
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
23. The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer.
Lian Y; Li Z; Fan Y; Huang Q; Chen J; Liu W; Xiao C; Xu H
Am J Transl Res; 2017; 9(12):5496-5506. PubMed ID: 29312501
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
25. Integrated RNA Sequencing and Single-Cell Mass Cytometry Reveal a Novel Role of LncRNA HOXA-AS2 in Tumorigenesis and Stemness of Hepatocellular Carcinoma.
Lu Q; Gao J; Tang S; Li Z; Wang X; Deng C; Hu J; Tao Y; Wang Q
Onco Targets Ther; 2020; 13():10901-10916. PubMed ID: 33149607
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA HOXA-AS2 promotes the expression levels of hypoxia-inducible factor-1α and programmed death-ligand 1, and regulates nasopharyngeal carcinoma progression via miR-519.
Wang S; You H; Yu S
Oncol Lett; 2020 Nov; 20(5):245. PubMed ID: 32973958
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
Huang R; Liao X; Wang X; Li Q
J Cancer; 2021; 12(7):2151-2164. PubMed ID: 33754013
[No Abstract] [Full Text] [Related]
28. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer.
Ding J; Xie M; Lian Y; Zhu Y; Peng P; Wang J; Wang L; Wang K
Oncogenesis; 2017 Jan; 6(1):e288. PubMed ID: 28112720
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of
Soghala S; Harsiny K; Momeni P; Hatami M; Kholghi Oskooei V; Hussen BM; Taheri M; Ghafouri-Fard S
Heliyon; 2022 Oct; 8(10):e11155. PubMed ID: 36299522
[TBL] [Abstract][Full Text] [Related]
30. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer.
Li Q; Dai Y; Wang F; Hou S
Neoplasma; 2016; 63(6):977-983. PubMed ID: 27596298
[TBL] [Abstract][Full Text] [Related]
31. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
[TBL] [Abstract][Full Text] [Related]
32. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
34. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
Wang H; Wang J; Liang CF; Zhou T
Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population.
Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Elsayed RS; Sherif MM; Abbas A; El Shabrawy M
J Gene Med; 2021 Dec; 23(12):e3381. PubMed ID: 34312940
[TBL] [Abstract][Full Text] [Related]
36. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Gong J; Zhang H; He L; Wang L; Wang J
Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
[TBL] [Abstract][Full Text] [Related]
37. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
[TBL] [Abstract][Full Text] [Related]
38. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of the long non-coding RNA TUSC7 promotes NSCLC cell proliferation and correlates with poor prognosis.
Wang Z; Jin Y; Ren H; Ma X; Wang B; Wang Y
Am J Transl Res; 2016; 8(2):680-7. PubMed ID: 27158360
[TBL] [Abstract][Full Text] [Related]
40. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
